Other grades of this product :
| PF-04457845 Basic information |
| Product Name: | PF-04457845 | | Synonyms: | N-3-Pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-1-piperidinecarboxamide;PF-04457845;N-Pyridazin-3-yl-4-(3-{[5-(trifluoroMethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxaMide;PF-04457845;PF04457845;1-Piperidinecarboxamide, n-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2- pyridinyl]oxy]phenyl]methylene]-;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;CS-1549;PF-04457845 >=98% (HPLC) | | CAS: | 1020315-31-4 | | MF: | C23H20F3N5O2 | | MW: | 455.43 | | EINECS: | | Product Categories: | | Mol File: | 1020315-31-4.mol |
| PF-04457845 Chemical Properties |
| Boiling point | 687.0±55.0 °C(Predicted) | | density | 1.389±0.06 g/cm3(Predicted) | | storage temp. | room temp | | form | powder | | pka | 12.72±0.20(Predicted) | | color | white to beige |
| PF-04457845 Usage And Synthesis |
| Biochem/physiol Actions | PF-04457845 is a potent, orally active, irreversible inhibitor of fatty acid amide hydrolase (FAAH), the principle enzyme involved in the degradation of the endocannabinoid anandamide. PF-04457845 is a covalent inhibitor that carbamylates FAAH′s serine nucleophile. It was shown to be both potent and selective against other serine hydrolases. It has an IC50 value of 7.2 nM for human FAAH. The endocannabinoid system is a target for therapeutic pain relief. In a rat model of inflammatory pain, PF-04457845 produced significant reduction of inflammatory pain with efficacy comparable to that of naproxen at 10 mg/kg. |
| PF-04457845 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye